Clinical Trial Update: IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating IN10018 in combination with KN046 and standard chemotherapy for advanced pancreatic cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• IN10018
• KN046

Snippet

Sponsor: InxMed (Shanghai) Co., Ltd. | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: RECRUITING